CHUGAI PHARMACEUTICAL CO., LTD. (4519) Cash flow
Market cap
¥14.42T
P/E ratio
35.2x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
| 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash from operations | 77,542 | 53,521 | 37,034 | 62,918 | 38,787 | 107,623 | 119,074 | 206,641 | 205,035 | 279,626 | 244,112 | 409,925 | 447,600 | 386,280 |
| Capital expenditures | - | - | - | - | - | - | -71,785 | -53,009 | -57,040 | -65,969 | -62,625 | -71,948 | -50,415 | -76,273 |
| Cash from investing | -54,901 | -13,213 | -14,351 | -45,269 | -10,107 | -36,718 | -74,060 | -81,741 | -98,312 | -118,927 | -145,994 | -37,290 | -227,365 | -201,273 |
| Cash from financing | -22,792 | -23,169 | -24,388 | -28,467 | -33,415 | -29,563 | -35,014 | -66,872 | -99,497 | -107,408 | -145,641 | -139,331 | -141,006 | -307,886 |